Fluphenazine hydrochloride

CAS No. 146-56-5

Fluphenazine hydrochloride( —— )

Catalog No. M11996 CAS No. 146-56-5

Fluphenazine dihydrochloride is a phenothiazine-class D1DR and D2DR inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
50MG 40 In Stock
100MG 48 In Stock
200MG 70 In Stock
500MG 111 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fluphenazine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Fluphenazine dihydrochloride is a phenothiazine-class D1DR and D2DR inhibitor.
  • Description
    Fluphenazine dihydrochloride is a phenothiazine-class D1DR and D2DR inhibitor; used to deliver Fluphenazine to biological systems in studies probing the effects and metabolic fates of this commonly used dopamine antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    146-56-5
  • Formula Weight
    510.44
  • Molecular Formula
    C22H28Cl2F3N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 38mg/mL
  • SMILES
    Cl.Cl.OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Qin ZH, Weiss B. Eur J Pharmacol. 1994 Sep 15;269(1):25-33.
molnova catalog
related products
  • MLS1547

    MLS1547 is a highly efficacious agonist of G protein-biased dopamine D2 receptor with a Ki of 1.2 μM. MLS1547 stimulates D2R G protein-mediated signaling with EC50 of 0.37 μM in a calcium mobilization assay.

  • Sultopride hydrochlo...

    Sultopride Hydrochloride is a selective dopamine D2 and D3 receptor antagonist.

  • Medifoxamine

    Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake.